Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ITOS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Iteos Therapeutics Inc

ITOS
Current price
10.26 USD -0.06 USD (-0.58%)
Last closed 10.26 USD
ISIN US46565G1040
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 392 689 184 USD
Yield for 12 month -34.77 %
1Y
3Y
5Y
10Y
15Y
ITOS
21.11.2021 - 28.11.2021

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), as well as engages the Fc gamma receptor to activate dendritic cells, natural killer cells, T lymphocytes, and macrophages and to promote the release of cytotoxic granules and antibody-dependent cellular cytotoxicity activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonist program; EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to reverse immunosuppression and restore T cell proliferation in the tumor microenvironment; and EOS-215, a monoclonal antibody which antagonizes triggering receptor expressed on triggering receptor expressed on myeloid cells 2. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts. Address: 321 Arsenal Street, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.00 USD

P/E Ratio

Dividend Yield

Financials ITOS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+35 000 000 USD

Last Year

+12 595 000 USD

Current Quarter

Last Quarter

Current Year

+33 762 000 USD

Last Year

+11 697 000 USD

Current Quarter

Last Quarter

EBITDA -148 648 992 USD
Operating Margin TTM -428.31 %
Price to Earnings
Return On Assets TTM -14.54 %
PEG Ratio
Return On Equity TTM -23.68 %
Wall Street Target Price 11.00 USD
Revenue TTM 35 000 000 USD
Book Value 14.72 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM 35 000 000 USD
Earnings per share -3.05 USD
Diluted Eps TTM -3.05 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -88.60 %
Profit Margin

Stock Valuation ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.56
Enterprise Value Revenue 1.26
Price Sales TTM 11.22
Enterprise Value EBITDA 0.50
Price Book MRQ 0.70

Technical Indicators ITOS

For 52 Weeks

4.80 USD 18.13 USD
50 Day MA 9.38 USD
Shares Short Prior Month 2 700 947
200 Day MA 8.16 USD
Short Ratio 1.04
Shares Short 2 832 859
Short Percent 9.08 %